SCHEMBL30315440

SCHEMBL30315440

CC(C)n1cnc2c(NCCN3CCNC(=O)C3)nc(-c3csc4ccccc34)nc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 1/20 0.62
▸ CDK5 Q00535 10/20 0.39
▸ CDK1 P06493 10/20 0.39
▸ CDK5R1 Q15078 8/20 0.39
▸ CCNB2 O95067 7/20 0.39
▸ CCNB1 P14635 7/20 0.39
▸ CCNB3 Q8WWL7 7/20 0.39
▸ TLR9 Q9NR96 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CDK2 P24941 4/20 0.36
▸ CCNE1 P24864 3/20 0.36
▸ CCNE2 O96020 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ CCNA1 P78396 1/20 0.36
▸ CLK2 P49760 2/20 0.35
▸ DYRK1A Q13627 2/20 0.35
▸ CLK4 Q9HAZ1 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2314533 1.00 AHR (0.62) AHRCDK5CDK1CDK5R1CCNB2
SCHEMBL2310920 0.89 AHR (0.64) AHRCDK5CDK1CDK5R1CCNB2
SCHEMBL30315325 0.89 AHR (0.64) AHRCDK5CDK1CDK5R1CCNB2
SCHEMBL2312403 0.81 CDK1 (0.45) CDK5CDK1CDK5R1CCNB2CCNB1
SCHEMBL30315385 0.81 CDK1 (0.45) CDK5CDK1CDK5R1CCNB2CCNB1
SCHEMBL2318576 0.81 AHR (0.69) AHRCDK5CDK1CDK5R1CCNB2
SCHEMBL2314146 0.80 AHR (0.70) AHRCDK5CDK1CDK5R1CCNB2
SCHEMBL30315381 0.80 AHR (0.70) AHRCDK5CDK1CDK5R1CCNB2
SCHEMBL15011335 0.79 AHR (0.87) AHRCDK5CDK1CCNB2CCNB1
SCHEMBL24689885 0.79 AHR (0.72) AHRCDK5CDK1CDK5R1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524604-B1 EXPANDED HEMATOPOIETIC STEM CELLS FROM CORD BLOOD AND THEIR THERAPEUTIC USE NOVARTIS AG (CH) 2023-03-29 — — EP disclosed
Send feedback